Ahmed et al. Transduction of interleukin-2 antiapoptotic and proliferative signals via akt protein kinase vol. 94 pp. 3627-3632 Apr. 1997.* |
Skorski et al. Transformation of hematopietic cells by BCR/ABL requireS activation of a Pl-3k/Akt-dependent pathway The EMBO journal vol. 16 No. 20 pp. 6151-6161, 1997.* |
Goeddel, Gene Expression Technology, Methods in Enzymology, vol. 185, 1990, pp. 487-511.* |
Madrid, L. V., et al., “Akt Suppresses Apoptosis by Stimulating the Transactivation Potential of the RelA/p65 Subunit of NF-κB,” Molecular and Cellular Biology 20(5):1626-1638 (2000). |
EPO International Search Report for PCT/US 00/23483, mailed Jan. 11, 2001. |
Alessi et al., The EMBO Journal 15(23):6541-6551, 1996. |
Bailey, J. E. et al., “Inverse Metabolic Engineering: A Strategy for Directed Genetic Engineering of Useful Phenotypes,” Biotechnology and Bioengineering, 52:109-121, 1996. |
Brott, B. K. et al., “MEK2 Is a Kinase Related to MEK1 and Is Differentially Expressed in Murine Tissues,” Cell Growth & Differentiation, 4:921-929, 1993. |
Butler, A. A. et al., “Insulin-like growth factor-I receptor signal transduction: at the interface between physiology and cell biology,” Comparative Biochemistry and Physiology, Part B, 121:19-26, 1998. |
Coffer, P. J. et al, “Protein kinase B (c-Akt): a multifunctional mediator for phosphatidylinositol 3-kinase activation,” Biochem. J., 335:1-13, 1998. |
Datta, S. R. et al., “Cellular survival: a play in three Akts,” Genes & Development, 13(22):2905-2927. |
Furlanetto, R. W. et al., “14-3-3 Proteins interact with the insulin-like growth factor receptor but not the insulin receptor,” Biochem. J., 327:765-771, 1997. |
Fussenegger, M. and Bailey, J. E., “Control of Mammalian Cell Proliferation as an Important Strategy in Cell Culture Technology, Cancer Therapy and Tissue Engineering,” Cell Engineering, Mohamed Al-Rubeai, ed., Kluwer Academic, Dordrecht, Boston, London, 1999, pp. 186-219. |
Fussenegger, M. and Bailey, J. E., “Molecular Regulation of Cell-Cycle Progression and Apoptosis in Mammalian Cells: Implications for Biotechnology,” Biotechnol. Prog., 14(6):807-833, 1998. |
Fussenegger, M. et al., “Genetic optimization of recombinant glycoprotein production by mammalian cells,” Tibtech, 17:35-42, 1999. |
Galetic, I. et al., “Mechanism of Protein Kinase B Activation by Insulin/Insulin-Like Growth Factor-1 Revealed by Specific Inhibitors of Phosphoinositide 3-Kinase—Significance for Diabetes and Cancer,” Pharmacol. Ther., 82(2-3):409-425, 1999. |
Greulich, H. and Erickson, R. L., “An Analysis of Mek1 Signaling in Cell Proliferation and Transformation,” The Journal of Biological Chemistry, 273(21):13280-13288, 1998. |
Hannigan, G. E. et al., “Regulation of cell adhesion and anchorage-dependent growth by a new β1-integrin-linked protein kinase,” Nature, 379:91-96, 1996. |
Hsu, S. Y. et al., “Interference of BAD (Bcl-xL/Bcl-2-Associated Death Promoter)-Induced Apoptosis in Mammalian Cells by 14-3-3 Isoforms and P11,” Molecular Endocrinology, 11(12):1858-1865, 1997. |
Klippel, A. et al., Membrane Localization of Phosphatidylinositol 3-Kinase is Sufficient to Activate Multiple Signal-Transducing Kinase Pathways, Molecular and Cellular Biology, 16(8):4117-4127, 1996. |
Konishi, H. et al., “Opposing Effects of Protein Kinase C δ and Protein Kinase B α on H2O2-Induced Apoptosis in CHO Cells,” Biochemical and Biophysical Research Communications, 264:840-846, 1999. |
Lee, K. H. et al., “Deregulated Expression of Cloned Transcription Factor E2F-1 in Chinese Hamster Ovary Cells Shifts Protein Patterns and Activates Growth in Protein-Free Medium,” Biotechnology and Bioengineering, 50:273-279, 1996. |
Le Gall, M. et al., “The p42/p44 MAP kinase pathway prevents apoptosis induced by anchorage and serum removal,” Molecular Biology of the Cell, 11(3):1103-1112, 2000. |
Lopaczynski, W., “Differential regulation of signaling pathways for insulin and insulin-like growth factor I,” Acta Biochimica Polonica, 46(1):51-60, 1999. |
Mueckler, M., “Facilitative glucose transporters,” Eur. J. Biochem., 219:713-725, 1994. |
O'Connor, R. et al., “Identification of Domains of the Insulin-Like Growth Factor I Receptor That Are Required for Protection from Apoptosis,” Molecular and Cellular Biology, 17(1):427-435, 1997. |
Owaki, H. et al., “Extracellular Signal-Regulated Kinases in T Cells: Characterization of Human ERK1 and ERK2 cDNAs1, 2,” Biochemical and Biophysical Research Communications, 182(3):1416-1422, 1992. |
Ozes, O. N. et al., “NF-κB activation by tumour necrosis factor requires the Akt serine-threonine kinase,” Nature, 401:82-85, 1999. |
Pages, G. et al., “Constitutive mutant and putative regulatory serine phosphorylation site of mammalian MAP kinase kinase (MEK 1),” EMBO Journal, 13(13):3003-3010, 1994. |
Pak, S. C. O. et al., “Super-CHO—A cell line capable of autocrine growth under fully defined protein-free conditions,” Cytochnology, 22:139-146, 1996. |
Paul, A. et al., “Stress-activated Protein Kinases: Activation, Regulation and Function,” Cell. Signal., 9(6):403-410, 1997. |
Pelech, S. L., “MAP kinase-dependent pathways in cell cycle control,” Prog. Cell Cycle Res., 1:33-52, 1995, Abstract. |
Rasmussen, B. et al., “Isolation, characterization and recombinant protein expression in Veggie-CHO: A serum-free CHO host cell line,” Cytotechnology, 28:31-42, 1998. |
Romashkova, J. A. and Makarov, S. S, “NF-κB is a target of AKT in anti-apoptotic PDGF signalling,” Nature, 401:86-89, 1999. |
Samadder, P. and Arthur, G., “Decreased Sensitivity to 1-O-Octadecyl-2-O-methyl-glycerophosphocholine in MCF-7 Cells Adapted for Serum-free Growth Correlates with Constitutive Association of Raf-1 with Cellular Membranes,” Cancer Research, 59:4808-4815, 1999. |
Tang, Y. et al., “The Akt proto-oncogene links Ras to Pak and cell survival signals,” Journal of Biological Chemistry, 275(13):9106-9109, 2000, Abstract. |
Waters, S. B. and Pessin, J. E., “Insulin receptor substrate 1 and 2 (IRS1 and IRS2): what a tangled web we weave,” Cell Biology, 6:1-4, 1996. |
Woessmann, W. et al., “An essential role for mitogen-activated protein kinases, ERKs, in preventing heat-induced cell death,” Journal of Cellular Biochemistry, 74(4):648-662, 1999, Abstract. |
Yip-Schneider, M. T. et al., “Lack of elevated MAP kinase (Erk) activity in pancreatic carcinomas despite oncogenic K-ras expression,” International Journal of Oncology, 15(2):271-279, 1999, Abstract. |
Zanghi, J. A. et al., “Serum Protects Protein-Free Competent Chinese Hamster Ovary Cells Against Apoptosis Induced by Nutrient Deprivation in Batch Culture,” Biotechnology and Bioengineering, 64(1):108-120, 1999. |